American Registry of Ambulatory or acutely decompensated heart failure (AMERICCAASS Registry): First 1000 patients
Clinical Cardiology · 2024
DOI: 10.1002/clc.24182 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Cardiology, 2024. Verfasst von Juan Esteban Gómez-Mesa und 34 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Fundación Valle del Lili, Cali, Colombia. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme Inhibitors, Heart Failure. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Roche Laboratory.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
About 80% of cardiovascular diseases (including heart failure [HF]) occur in low‐income and developing countries. However, most clinical trials are conducted in developed countries. Hypothesis The American Registry of Ambulatory or Acutely Decompensated Heart Failure (AMERICCAASS) aims to describe the sociodemographic characteristics of HF, comorbidities, clinical presentation, and pharmacological management of patients with ambulatory or acutely decompensated HF in America. Methodology Descriptive, observational, prospective, and multicenter registry, which includes patients >18 years with HF in an outpatient or hospital setting. Collected information is stored in the REDCap electronic platform. Quantitative variables are defined according to the normality of the variable using the Shapiro–Wilk test.
Results
This analysis includes data from the first 1000 patients recruited. 63.5% were men, the median age of 66 years (interquartile range 56.7–75.4), and 77.6% of the patients were older than 55 years old. The percentage of use of the four pharmacological pillars at the time of recruitment was 70.7% for beta‐blockers (BB), 77.4% for angiotensin‐converting enzyme inhibitor (ACEI)/angiotensin II receptor blocker (ARB II)/angiotensin receptor‐neprilysin inhibitor (ARNI), 56.8% for mineralocorticoid receptor antagonists (MRA), and 30.7% for sodium–glucose cotransporter type‐2 inhibitors (SGLT2i). The main cause of decompensation in hospitalized patients was HF progression (64.4%), and the predominant hemodynamic profile was wet‐warm (68.3%).
Conclusions
AMERICCAASS is the first continental registry to include hospitalized or outpatient patients with HF. Regarding optimal medical therapy, approximately a quarter of the patients still need to receive BB and ACEI/ARB/ARNI, less than half do not receive MRA, and more than two‐thirds do not receive SGLT2i.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Fundación Valle del Lili, Cali, Colombia.
- Department of Health Sciences, Universidad Icesi, Cali, Colombia.
- Fundación Valle del Lili, Centro de investigaciones Clínicas, Cali, Colombia.
- Instituto De Cardiología J. F. Cabral, Department of Heart Failure and Pulmonary Hypertension, Corrientes, Argentina.
- Department of Internal Medicine, Hospital Regional de Zacapa, Ciudad de Zacapa, Guatemala.
- Department of Cardiology, Todo por el Corazón cardiology center, Manizales, Colombia.
ORCID-Profile: Juan Esteban Gómez-Mesa, Juliana María Gutiérrez-Posso, Manuela Escalante-Forero, Brayan Daniel Córdoba-Melo, Paula Andrea Cárdenas-Marín, Eduardo R Perna, Mádelyn Raquel Valle-Ramos, Germán Camilo Giraldo-González, Noel Alberto Flórez-Alarcón, Ida Fabiola Rodríguez-Caballero, Cristian Núñez-Carrizo, Luz Teresa Cabral-Gueyraud, Sarah Raquel Marte-Arias, Amada Álvarez-Sangabriel, Kwame van der Hilst, Sergio Roberto Fausto Ovando, Luis Arturo Rodríguez, Juan Pablo Escalante, Gabriela Ormaechea-Gorricho, María Juliana Rodríguez-González, Sebastián Campbell-Quintero, Guillermo Trout-Guardiola, Ana Margarita Jerez-Castro, Mark Drazner, Daniel Quesada-Chaves, Alexander Romero-Guerra, Víctor Alejandro Rossel-Mariángel, Mario Speranza
Förderung
- Roche Laboratory
Zitieren
APA
Gómez-Mesa, J. E., Gutiérrez-Posso, J. M., Escalante-Forero, M., Córdoba-Melo, B. D., Cárdenas-Marín, P. A., Perna, E. R., Valle-Ramos, M. R., Giraldo-González, G. C., Flórez-Alarcón, N. A., Rodríguez-Caballero, I. F., Núñez-Carrizo, C., Cabral-Gueyraud, L. T., Marte-Arias, S. R., Hardin, E. A., Álvarez-Sangabriel, A., Menjívar-De Ramos, M. E., van der Hilst, K., Cruz-Díaz, L. J., Fausto Ovando, S. R., …, & Speranza, M. (2024). American Registry of Ambulatory or acutely decompensated heart failure (AMERICCAASS Registry): First 1000 patients. Clinical Cardiology. https://doi.org/10.1002/clc.24182
Vancouver
Gómez-Mesa JE, Gutiérrez-Posso JM, Escalante-Forero M, Córdoba-Melo BD, Cárdenas-Marín PA, Perna ER, et al. American Registry of Ambulatory or acutely decompensated heart failure (AMERICCAASS Registry): First 1000 patients. Clinical Cardiology. 2024. doi:10.1002/clc.24182
BibTeX
@article{GmezMesa2024,
author = {Gómez-Mesa, Juan Esteban and Gutiérrez-Posso, Juliana María and Escalante-Forero, Manuela and Córdoba-Melo, Brayan Daniel and Cárdenas-Marín, Paula Andrea and Perna, Eduardo R and Valle-Ramos, Mádelyn Raquel and Giraldo-González, Germán Camilo and Flórez-Alarcón, Noel Alberto and Rodríguez-Caballero, Ida Fabiola and Núñez-Carrizo, Cristian and Cabral-Gueyraud, Luz Teresa and Marte-Arias, Sarah Raquel and Hardin, Elizabeth Ashley and Álvarez-Sangabriel, Amada and Menjívar-De Ramos, María Eugenia and van der Hilst, Kwame and Cruz-Díaz, Licurgo Jacob and Fausto Ovando, Sergio Roberto and Rodríguez, Luis Arturo and Escalante, Juan Pablo and Ormaechea-Gorricho, Gabriela and Bornancini, Norberto Raul and Rodríguez-González, María Juliana and Campbell-Quintero, Sebastián and González-Hormostay, Raquel E and Oviedo-Pereira, Guillermo and Trout-Guardiola, Guillermo and Encina, Juan Justiniano and Jerez-Castro, Ana Margarita and Drazner, Mark and Quesada-Chaves, Daniel and Romero-Guerra, Alexander and Rossel-Mariángel, Víctor Alejandro and Speranza, Mario},
title = {American Registry of Ambulatory or acutely decompensated heart failure (AMERICCAASS Registry): First 1000 patients},
journal = {Clinical Cardiology},
year = {2024},
doi = {10.1002/clc.24182}
}
EUVIMED